EE03748B1 - Pneumokandiinderivaat kasutamiseks seenhaiguste ravis - Google Patents

Pneumokandiinderivaat kasutamiseks seenhaiguste ravis

Info

Publication number
EE03748B1
EE03748B1 EEP199900088A EE9900088A EE03748B1 EE 03748 B1 EE03748 B1 EE 03748B1 EE P199900088 A EEP199900088 A EE P199900088A EE 9900088 A EE9900088 A EE 9900088A EE 03748 B1 EE03748 B1 EE 03748B1
Authority
EE
Estonia
Prior art keywords
inhibitors
antifungal
combination
xmp
polyenes
Prior art date
Application number
EEP199900088A
Other languages
English (en)
Other versions
EE9900088A (et
Inventor
F. Bartizal Kenneth
K. Abruzzo George
M. Flattery Amy
Original Assignee
Merck & Co., Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9620739.4A external-priority patent/GB9620739D0/en
Application filed by Merck & Co., Inc. filed Critical Merck & Co., Inc.
Publication of EE9900088A publication Critical patent/EE9900088A/et
Publication of EE03748B1 publication Critical patent/EE03748B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1751—Bactericidal/permeability-increasing protein [BPI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EEP199900088A 1996-09-12 1997-09-09 Pneumokandiinderivaat kasutamiseks seenhaiguste ravis EE03748B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2632796P 1996-09-12 1996-09-12
GBGB9620739.4A GB9620739D0 (en) 1996-10-04 1996-10-04 Antifungal combination therapy
PCT/US1997/015987 WO1998010782A1 (en) 1996-09-12 1997-09-09 Antifungal combination therapy

Publications (2)

Publication Number Publication Date
EE9900088A EE9900088A (et) 1999-10-15
EE03748B1 true EE03748B1 (et) 2002-06-17

Family

ID=26310166

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900088A EE03748B1 (et) 1996-09-12 1997-09-09 Pneumokandiinderivaat kasutamiseks seenhaiguste ravis

Country Status (21)

Country Link
EP (1) EP0925070B1 (et)
JP (1) JP3288051B2 (et)
KR (1) KR100380871B1 (et)
CN (1) CN1235554A (et)
AT (1) ATE248625T1 (et)
AU (1) AU721334B2 (et)
CA (1) CA2265824C (et)
CY (1) CY2481B1 (et)
CZ (1) CZ88499A3 (et)
DE (1) DE69724626T2 (et)
DK (1) DK0925070T3 (et)
EA (1) EA002469B1 (et)
EE (1) EE03748B1 (et)
ES (1) ES2203819T3 (et)
IL (1) IL128870A0 (et)
NO (1) NO991207L (et)
NZ (1) NZ334446A (et)
PL (1) PL333282A1 (et)
PT (1) PT925070E (et)
SK (1) SK29999A3 (et)
WO (1) WO1998010782A1 (et)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI0753001T1 (en) * 1994-11-08 1999-12-31 Glaxo Wellcome S.A. Antifungal sordaridin derivatives
USRE38984E1 (en) 1996-09-12 2006-02-14 Merck & Co., Inc. Antifungal combination therapy
AUPQ066399A0 (en) * 1999-05-31 1999-06-24 Fujisawa Pharmaceutical Co., Ltd. Antifungal combination use
AUPQ462399A0 (en) * 1999-12-13 2000-01-13 Fujisawa Pharmaceutical Co., Ltd. New use
KR100680464B1 (ko) * 2000-06-28 2007-02-08 주식회사 하이닉스반도체 반도체 소자의 캐패시터 제조 방법
JPWO2002098463A1 (ja) * 2001-06-05 2004-09-16 財団法人新産業創造研究機構 抗真菌組成物
SI1867332T1 (sl) 2005-04-07 2011-11-30 Toyama Chemical Co Ltd Farmacevtska sestava in postopek z rabo v kombinaciji s protiglivičnim sredstvom
TWI385169B (zh) 2005-10-31 2013-02-11 Eisai R&D Man Co Ltd 經雜環取代之吡啶衍生物及含有彼之抗真菌劑
JP5132569B2 (ja) * 2006-10-06 2013-01-30 富山化学工業株式会社 フェニルアミジン誘導体を含有する医薬組成物および抗真菌剤を組み合わせて使用する方法
TWI426918B (zh) * 2007-02-12 2014-02-21 Merck Sharp & Dohme Ｉｌ-２３拮抗劑於治療感染之用途
WO2009129525A2 (en) * 2008-04-18 2009-10-22 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Antifungal and anti-cariogenic cellobio-oligosaccharides produced by dextransucrase
CN102274216B (zh) * 2010-06-10 2013-04-10 吉林大学 一种提高氟康唑抗真菌作用的增效剂
CN102274217B (zh) * 2010-06-10 2013-04-10 吉林大学 三氯生作为抗真菌药物氟康唑增效剂的新用途
CN102274215B (zh) * 2010-06-10 2013-04-10 吉林大学 一种具有与氟康唑协同抗真菌作用的增效剂
WO2012060448A1 (ja) 2010-11-05 2012-05-10 エーザイ・アール・アンド・ディー・マネジメント株式会社 抗真菌剤としての併用医薬組成物
BR112013029912A2 (pt) * 2011-05-24 2016-08-09 Bayer Cropscience Lp combinações sinergísticas de fungicidas de polieno e peptídeos não ribossomais e métodos de uso relacionados
CN102319326A (zh) * 2011-07-23 2012-01-18 李玮 一种治疗脚癣的浸药卫生纸
CN114652836B (zh) * 2022-03-25 2023-06-20 山东大学 T3ss小分子抑制剂及其筛选方法和应用
CN116473985A (zh) * 2023-03-29 2023-07-25 暨南大学 一种多烯类抗真菌药物组合物及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378804A (en) * 1993-03-16 1995-01-03 Merck & Co., Inc. Aza cyclohexapeptide compounds

Also Published As

Publication number Publication date
WO1998010782A1 (en) 1998-03-19
IL128870A0 (en) 2000-06-01
EA199900283A1 (ru) 1999-08-26
EP0925070B1 (en) 2003-09-03
NZ334446A (en) 2000-11-24
NO991207L (no) 1999-05-11
EE9900088A (et) 1999-10-15
CZ88499A3 (cs) 1999-10-13
JP2000503675A (ja) 2000-03-28
ES2203819T3 (es) 2004-04-16
AU721334B2 (en) 2000-06-29
AU4339297A (en) 1998-04-02
KR20000036054A (ko) 2000-06-26
CY2481B1 (en) 2005-06-03
PL333282A1 (en) 1999-11-22
DE69724626T2 (de) 2004-07-29
SK29999A3 (en) 2000-02-14
KR100380871B1 (ko) 2003-04-18
DK0925070T3 (da) 2003-12-01
JP3288051B2 (ja) 2002-06-04
CN1235554A (zh) 1999-11-17
NO991207D0 (no) 1999-03-11
EA002469B1 (ru) 2002-06-27
DE69724626D1 (de) 2003-10-09
ATE248625T1 (de) 2003-09-15
PT925070E (pt) 2003-12-31
CA2265824C (en) 2004-11-09
EP0925070A1 (en) 1999-06-30
CA2265824A1 (en) 1998-03-19

Similar Documents

Publication Publication Date Title
EE03748B1 (et) Pneumokandiinderivaat kasutamiseks seenhaiguste ravis
Rousey et al. Low-dose amphotericin B prophylaxis against invasive Aspergillus infections in allogeneic marrow transplantation
Galgiani Fluconazole, a new antifungal agent
Meis et al. Current management of fungal infections
WO2000072865A3 (en) Antifungal combination use
WO2003086408A8 (en) Use of a2a adenosine receptor agonists for the treatment of inflammatory diseases
BR0207024A (pt) Medicamento com ação inicial rápida para o tratamento de disfunção sexual
Clark et al. The role of ribavirin in direct acting antiviral drug regimens for chronic hepatitis C
US6069126A (en) Antifungal combination therapy
EP1157698A3 (en) Treatment of inflammatory diseases with oxypurine nucleosides
BR0211970A (pt) Uso de bibn4096 em combinação com outras drogas antienxaqueca para o tratamento de enxaqueca
Macura The Influence of Some Antifungal Drugs on In Vitro Adherence of Candida albicans to Human Buccal Epithelial Cells: Der Einfluß einiger Antimyzetika auf die Adhärenz von Candida albicans in vitro an Epithelzellen der Mundschleimhaut des Menschen
BR9917605A (pt) Composição substituta de plasma
Smith Topical antifungal agents
MXPA99002401A (en) Antifungal combination therapy
IT1297538B1 (it) Enteroclisma di lattulosio/lattitolo con o senza aggiunta di neomicina per la cura della encefalopatia portosistemica acuta
Calandra et al. Response to van Saene et al.'s comment on" Prevention of severe Candida infections in non-neutropenic, high-risk, critically ill patients"
HUP0000127A2 (hu) Több hatóanyagot tartalmazó antimikotikus kompozíció
刘光第 The Hybrid’s Dilemma
蒋松鹤 et al. SUMMARY OF RESEARCHES ON THE TREATMENT OF PROTRUSION OF LUMBAR INTERVERTEBRAL DISC BY
AU9530101A (en) Medicinal composition and in particular its use in fluid therapy
IT1312003B1 (it) Uso di lonidamina e suoi derivati nel trattamento di affezioni causateda retrovirus.

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

MM4A Lapsed by not paying the annual fees

Effective date: 20040909